The role of high-dose therapy and autologous stem cell transplantation in patients with primary refractory Hodgkin's lymphoma: a report from the Gruppo Italiano per lo Studio dei Linfomi (GISL).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples